Procyon Advisors
LMAT icon

Procyon Advisors’s LeMaitre Vascular LMAT Stock Holding History

Procyon Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,097
Closed -$201K – 620
2026
Q2 		$201K Buy
+2,097
New +$215K 0.01% 555
2020
Q3 		– Sell
-16
Closed – – 678
2020
Q2 		$0 Hold
16
– – ﹤0.01% 1137
2020
Q1 		$0 Sell
16
-34
-68% -$1.05K ﹤0.01% 1089
2019
Q4 		$2K Buy
+50
New +$1.72K ﹤0.01% 895

Other funds holding LMAT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Conestoga Capital Advisors
Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Procyon Advisors's LMAT Position: Q3 2026 in Review

Procyon Advisors sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 2,097 shares — an estimated $201K sold.

Procyon Advisors first reported a position in LMAT in Q4 2019 and held it in 4 quarters. The position peaked at $201K in Q2 2026. 127 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Procyon Advisors reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
  • Procyon Advisors sold 2,097 LeMaitre Vascular shares in Q3 2026, an estimated $201K.
  • Procyon Advisors first reported a position in LeMaitre Vascular in Q4 2019 and held it in 4 quarters.
  • Procyon Advisors's LeMaitre Vascular position peaked at $201K in Q2 2026.
  • 127 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.